Skip to content

Clinical trials

Terminated Lung Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Status: Terminated Country / region: United States Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20033
20042
20052
20061
20072
20081
20092
20101
20112
20121
20131
20145
20172
20186
20192
20205
20213
20223
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated49

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Blueprint Medicines Corporation3
Complexa, Inc.2
Emory University2
InterMune2
Mallinckrodt2
Weill Medical College of Cornell University2
Aeris Therapeutics1
AstraZeneca1
CardiacAssist, Inc.1
Celgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases49
Respiratory Tract Diseases14
Lung Neoplasms12
Neoplasms8
Thoracic Neoplasms7
Carcinoma, Non-Small-Cell Lung6
Hypertension, Pulmonary6
Neoplasms by Site6
Pulmonary Fibrosis5
Bronchial Neoplasms4

Trials

Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.